-28
NPS Score
VS
Moderna Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 66
- TOTAL
RATINGS
Sarepta Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 34
- TOTAL
RATINGS
Moderna Therapeutics vs Sarepta Therapeutics
Compare Moderna Therapeutics versus Sarepta Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 66 employees and customers of Moderna Therapeutics and 34 employees and customers of Sarepta Therapeutics.
Moderna Therapeutics
Moderna Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Moderna Therapeutics. Their current valuation is $69.15B.
Sarepta Therapeutics
Sarepta Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Sarepta Therapeutics. Their current market cap is $11.66B.
2.9/5
Product Quality
3.7/5
3.1/5
Pricing
3.7/5
3.1/5
Customer Service
5/5
| 29% | Promoters |
|---|---|
| 14% | Passive |
| 57% | Detractors |
-9
NPS Score
| 36% | Promoters |
|---|---|
| 19% | Passive |
| 45% | Detractors |
Net Promoter Score
Winner by 19
See how Moderna Therapeutics compares to its competitors
Working at Moderna Therapeutics vs Working at Sarepta Therapeutics
50 / 100
CEO Rating
79 / 100
CEO Rating
Winner by 29%
Moderna Therapeutics
Moderna Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Sarepta Therapeutics
Employees at Sarepta Therapeutics rate their CEO, Douglas Ingram, 79/100. This score is 29% higher than the scores of Moderna Therapeutics' CEO, Stéphane Bancel.